L iterature on acute lung injury and the acute respiratory distress syndrome (ARDS) during pregnancy is sparse and consists largely of small case series. Overall mortality for both the mother and the fetus is high, and significant morbidity can persist even after initial recovery. Our goal is to provide a comprehensive overview of the topic and a conceptual framework to aid in the approach to a pregnant woman suspected of having ARDS. The evaluation and management can be divided into three parts that we cover in detail. As is the case with the general population, management begins with initial stabilization while the diagnosis is being evaluated. The second part, which occurs in concert with the first, is confirming the diagnosis of ARDS, finding a causative etiology, which may include causes unique to pregnancy, or making an alternative diagnosis. Unique to pregnancy, assessment of fetal wellbeing and development of a delivery plan is essential and is the third part of evaluating and managing ARDS in pregnancy. Due to the lack of evidence specific to pregnancy, management decisions must be drawn from studies done in the general population. Although ARDS during pregnancy is uncommon, when it does occur, optimum management requires multidisciplinary care from maternal-fetal medicine, neonatology, anesthesiology, and intensivist clinicians.
L iterature on acute lung injury and the acute respiratory distress syndrome (ARDS) during pregnancy is sparse and consists largely of small case series. Overall mortality for both the mother and the fetus is high, and significant morbidity can persist even after initial recovery. Our goal is to provide a comprehensive overview of the topic and a conceptual framework to aid in the approach to a pregnant woman suspected of having ARDS. The evaluation and management can be divided into three parts that we cover in detail. As is the case with the general population, management begins with initial stabilization while the diagnosis is being evaluated. The second part, which occurs in concert with the first, is confirming the diagnosis of ARDS, finding a causative etiology, which may include causes unique to pregnancy, or making an alternative diagnosis. Unique to pregnancy, assessment of fetal wellbeing and development of a delivery plan is essential and is the third part of evaluating and managing ARDS in pregnancy. Due to the lack of evidence specific to pregnancy, management decisions must be drawn from studies done in the general population. Although ARDS during pregnancy is uncommon, when it does occur, optimum management requires multidisciplinary care from maternal-fetal medicine, neonatology, anesthesiology, and intensivist clinicians.
Background on ARDS
ARDS is a form of respiratory failure characterized by acute hypoxemia and increased alveolar-capillary permeability resulting from diffuse and ongoing pulmonary inflammation (1) . The term adult respiratory distress syndrome was first proposed in 1967 and given its classic description in a series of 12 patients with acute respiratory distress (2) . Since that time, ARDS has been noted to occur in children and even mature infants so that ARDS is now called "acute" and not "adult" respiratory distress syndrome (1) .
The current definition of ARDS was proposed by Bernard et al. (3) and the American-European Consensus Conference. The criteria included: 1) acute onset; 2) a PaO 2 /FIO 2 ratio, or hypoxia score, of Յ200, regardless of positive endexpiratory pressure; 3) bilateral infiltrates on chest radiograph; and 4) a pulmonary artery occlusion pressure of Յ18 mm Hg or the absence of clinical evidence of left atrial hypertension. Acute lung injury was given similar criteria but with less severe hypoxemia, defined as a PaO 2 /FIO 2 ratio of Յ300. Although this definition has limitations, it is the current standard to allow clinicians to compare their patients with those in clinical trials (1) . Our approach is to apply the AmericanEuropean Consensus Conference definition while searching for the underlying cause of the lung injury, thus arriving at an appropriate diagnosis and treatment plan. It is particularly important to consider the possibility of cardiogenic pulmonary edema and volume overload in the differential diagnosis of ARDS in pregnancy because peripartum cardiomyopathy has a higher prevalence. Other imitators of ARDS that may also be considered include acute interstitial pneu-monia, acute eosinophilic pneumonia, acute bronchiolitis obliterans pneumonia, diffuse alveolar hemorrhage, and acute hypersensitivity pneumonitis, among others (4) . In particularly difficult cases, bronchoalveolar lavage, and even open lung biopsy, may be necessary to arrive at a diagnosis.
Different definitions have been used for obstetric-related ARDS, including ARDS during pregnancy or within 1 wk postpartum and ARDS during pregnancy or within 1 month postpartum (5, 6) . Given that it can take up to 6 wks from delivery for the majority of the physiologic changes of pregnancy to resolve, it may be appropriate to cover a more extended postpartum period than these two definitions. Alternatively, a very functional, albeit rudimentary, definition for obstetric-related ARDS could be ARDS that occurs during pregnancy, results from an obstetric cause, or is otherwise modified by an obstetric-related factor.
Pathophysiology and Clinical Course. Although a full discussion of the pathophysiology of ARDS is beyond the scope of this article, we will briefly review the salient points. Readers are referred to recent reviews of this topic for more detail (1, 7) .
ARDS results from inflammationinduced injury to the alveolar-capillary barrier. In the acute or exudative phase, this leads to flooding of the alveoli with high protein pulmonary edema and subsequent surfactant abnormalities and consolidation. Some cases resolve from this phase, which typically lasts 4 -7 days, whereas others progress to developing fibrosis and organization in the fibroproliferative phase. After 1-2 wks, those cases that progressed may begin to resolve with clearance of the pulmonary edema and inflammatory cells and reconstitution of the alveolar-capillary barrier.
Clinically, patients experience acute hypoxemic respiratory failure, often accompanied by dyspnea, tachypnea, and tachycardia. Diffuse bibasilar crackles or wheezing can be appreciated on auscultation of the chest, and tachypnea and cyanosis may be present. The chest radiograph is usually significant for bilateral diffuse alveolar and interstitial infiltrates, and differentiation from congestive heart failure or fluid overload may be difficult (Fig. 1) . Pulmonary hypertension and multiple organ dysfunction syndrome may also develop. As patients move into the resolution phase, there is gradual improvement in oxygenation, and most radiographic abnormalities resolve completely.
Outcomes. The mortality and morbidity rates of ARDS in the general population are high, with reported mortality ranging from 35% to 60% (1, 8) . In a series of 83 obstetric patients with ARDS, the antepartum mortality rate was 23% and the postpartum mortality rate was 50% (9) . Similarly, in another series of 28 obstetric patients with ARDS, the mortality rate was 39% and three of the 17 survivors had long-term sequelae (10) . Other authors have reported comparably high mortality rates (11, 12) . Multiple organ dysfunction syndrome has been reported as the most common cause of maternal death (5) . The long-term morbidity of ARDS was recently evaluated in a general adult population (13) . Of 195 patients enrolled, 40% died before discharge from the intensive care unit, and 11% of the remaining patients died over the 12-month period of follow-up, primarily due to preexisting medical conditions. Although lung function had largely normalized in surviving patients by 6 months, diffusion defects remained at 12 months. Quality of life was also significantly reduced. Although a large amount of morbidity outcome data is not available specifically for ARDS in pregnancy, morbidity in the obstetric patient base is likely high as well.
The effect of maternal ARDS on neonatal outcomes is not well studied, but high rates of fetal death, spontaneous preterm labor, and fetal heart rate abnormalities are reported. A high rate of perinatal asphyxia among surviving infants is also reported. In one series of 13 patients with ARDS who reached viability (Ն24 wks), the perinatal fetal death rate was 23% (10) . More recently, in a series of ten antepartum patients in the third trimester ventilated for ARDS, only five of the neonates survived intact after deliverydata were not available for one infant (5) . Spontaneous preterm labor and delivery was reported in six patients. Fetal heartrate abnormalities were reported in six of these pregnancies and occurred within 4 days of admission. Of the four infants who did not survive intact, two suffered perinatal asphyxia, one suffered perinatal asphyxia and cerebral palsy, and one suffered perinatal death.
Epidemiology and Pathogeneses
The prevalence of ARDS has been difficult to determine due to changes in the definition and the wide range of potential causes and clinical presentations (1) . Estimates range from 1.5 to 75 cases per 100,000 population, with the higher figure currently favored (1, 8) . The prevalence of ARDS during pregnancy has been estimated at 16 -70 cases per 100,00 pregnancies (5, 10, 12) . Due to the changing definition of ARDS and the lack of a firm definition for obstetric-related ARDS, this figure can be seen only as an estimate. Whether ARDS is more common or less common during pregnancy remains uncertain.
Any condition that results in an inflammation-induced injury to the alveolar-capillary interface can cause ARDS (Table 1 ). Due to differences in their response to some supportive therapies and in their morbidity and mortality, the causes of ARDS are traditionally separated into direct, or pulmonary, causes and indirect, or extrapulmonary, causes (15, 16) . The direct causes are those in which there is a direct injury to the lung, such as aspiration, and the indirect causes are those in which the injury to the lung is mediated through systemic inflammation, such as acute pancreatitis. We have further divided our discussion of the causes of ARDS into those that occur in both pregnant and nonpregnant individuals but are minimally affected by pregnancy, those that occur in both pregnant and nonpregnant individuals and are affected by pregnancy, and those that occur only in pregnancy or as a result of pregnancy. A variety of secondary, nonproximal factors that increase the risk of developing ARDS have also been suggested, including alcohol abuse, cirrhosis, cigarette smoking, chronic lung disease, and a low serum pH (17) (18) (19) (20) . Chronic alcohol abuse is also associated with increased severity of multiple organ dysfunction syndrome in patients with septic shock (20) .
Pathogeneses Minimally Affected by Pregnancy. A variety of clinical conditions have been identified as primary, proximal risk factors for the development of ARDS in the general, nonobstetric population that are minimally affected by pregnancy (1, 21) . Sepsis with prolonged hypotension is the most common cause of ARDS in both obstetric and nonobstetric patients. Causes of sepsis influenced by or unique to pregnancy are discussed below. Inhalational injury of smoke, volatile gasses, or other chemical lung irritants is unique in that ARDS may develop slowly and not manifest for up to 5 days after the actual injury (21, 22) . In contrast, transfusion-related acute lung injury, which can develop in response to the transfusion of any plasma-containing blood component, develops quickly, with symptoms occurring within 6 hrs of, and sometimes even during, the transfusion (21, 23) . Other conditions associated with the development of ARDS include pulmonary contusion, trauma (particularly with major long bone or pelvic fractures that can lead to fat embolism), acute pancreatitis, drug overdose, cutaneous surface burns, shock of any cause, and near drowning (21, 24) .
Pathogeneses Affected by Pregnancy. Pregnant patients are at particularly high risk for aspiration, especially during labor and delivery, due to the normal physiologic changes of pregnancy leading to decreased esophageal sphincter tone, delayed gastric emptying, and increased gastric pressure (25, 26) . The prevalence of aspiration in the obstetric population ranges from 1 to 15 per 10,000 and is more common with cesarean deliveries than with vaginal deliveries (26 -29) . The use of regional anesthesia, not allowing oral intake in the peripartum period, acid prophylaxis, and appropriate airway management can all be used to reduce the risk of aspiration pneumonitis (25, 26, 30) . Whereas large-volume aspiration can result in immediate symptoms such as tachypnea, tachycardia, cyanosis, hypoxemia, and hypotension, the symptoms from small-volume aspiration may be delayed by several hours (31) . Mild cases typically improve over 4 to 5 days, but more severe cases can lead to ARDS and even death (27, 31) . Pneumonia from aspiration of oral bacteria can also develop.
Acute pyelonephritis has been reported as a cause of antepartum ARDS, and up to 7% of pregnant women with pyelonephritis may develop respiratory insufficiency (32, 33) . Although pyelonephritis is not unique to pregnancy, it is common in obstetric patients, with a rate of 1-2.5% of pregnancies (33) . Furthermore, up to 25% of cases of untreated bacteruria during pregnancy can develop into acute pyelonephritis (34) . The ureteral dilation and increased collecting system volume that can result from the hormonal changes of pregnancy may account for these findings. Escherichia coli is the most common organism, and multiple organ dysfunction syndrome can occur as a result of endotoxin-mediated tissue damage (33, 35) . Additional complications include bacteremia in 10 -15% of pregnancy-related cases of pyelonephritis and anemia in 23%. The rate of recurrence is as high as 18% during the same pregnancy (33) . In addition to pyelonephritis, pregnant women are at an increased risk for other infections, including viral pneumonias, listeria, fungal infection with blastomycosis and coccidioidomycosis, and malaria (27) . Venous air embolism, which has been reported as a cause of ARDS, can occur during delivery, particularly by cesarean (30) .
Pathogeneses Unique to Pregnancy. Preeclampsia, which is reviewed elsewhere in this supplement, is a disorder unique to pregnancy and the puerperium and is often cited as a common cause of pregnancy-related ARDS. Preeclampsia complicates as many as 8% of pregnancies and can be recognized by the presence of new-onset hypertension and proteinuria (36, 37) . Due to increases in hydrostatic pressure from hypertension and alterations in capillary membrane permeability, pulmonary edema is present in nearly 3% of women with preeclampsia, typically after delivery, when plasma oncotic pressure is at its lowest (38 -40) . Some have suggested that invasive hemodynamic monitoring may be helpful in managing the volume shifts that can be seen in preeclampsia, but evidence of a proven benefit has not been published (36, 37) . Eclampsia (a seizure in a woman with preeclampsia not attributable to other causes), HELLP (hemolysis, elevated liver enzymes, and low blood platelet count) syndrome, and acute fatty liver of pregnancy are all also in the spectrum of preeclampsia and can result in ARDS (5, 37) .
Amniotic fluid embolism, which is also reviewed in this supplement, is a broad and poorly understood syndrome unique to pregnancy and believed to result from amniotic fluid elements entering the maternal circulation (41, 42) . Mechanical disruption of pulmonary blood flow and pathways of both sepsis and anaphylaxis have all been implicated in the clinical course. The classic presentation is of respiratory distress, cardiovascular collapse, and disseminated intravascular coagulation, all associated with labor or delivery. More subtle presentations have been reported, however, with fetal compromise as the only symptom. Although mortality rates have been reported as high as 80%, more recent data suggest a mortality rate of Ͻ30%.
Tocolytic-associated pulmonary edema occurs in nearly 10% of pregnant Figure 1 . Top, chest radiograph of a woman at 34 wks of gestation. Note the findings of mild cardiomegaly and prominent pulmonary vasculature that can be normal variants in late pregnancy. An abdominal shield is in place. Middle, chest radiograph of a woman at 19 wks of gestation with acute respiratory distress syndrome from pneumonia. Note the findings of diffuse, patchy alveolar, and interstitial infiltrates with areas of consolidation, bilateral pleural effusions, and small lung volumes. An abdominal shield and face tent are in place. Bottom, chest radiograph of a woman with peripartum cardiomyopathy obtained shortly after delivery. Note the findings of cardiomegaly, diffuse pulmonary edema with a "batwing" appearance on the left with sparing of the area above the diaphragm, and small pleural effusions.
women treated with beta-adrenergic agonists to prevent uterine contractions (43) . Classically, dyspnea, and sometimes chest pain, occurs during or within 24 hrs of sympathomimetic drug use and within 12 hrs postpartum in women who deliver despite tocolytic use (44) . Clinically apparent infection has been reported in several cases of tocolyticassociated pulmonary edema, and most cases of pulmonary edema have occurred in the setting of prolonged tocolysis for refractory preterm labor, which has been shown to represent silent chorioamnionitis in many instances (43, 45) . Thus, although the primary mechanism seems to be increased hydrostatic pressure, there may be an occult permeability lesion as well (44) . Treatment, which typically results in a rapid clinical response in Ͻ24 hrs, includes withdrawal of the tocolytic agent and supportive care with supplemental oxygen, occasionally diuretics, and rarely mechanical ventilation (43, 44) .
Chorioamnionitis, or intra-amniotic infection, results from bacteria present in the uterus at conception or that ascend from the vagina during the course of pregnancy (46) . Maternal fevers associated with fetal tachycardia, uterine tenderness, foul-smelling amniotic fluid, and leukocytosis all suggest the diagnosis, but the course can also be subclinical. Subsequently, in any pregnant patient with unexplained ARDS, chorioamnionitis must be considered, and diagnostic amniocentesis for Gram stain and culture should be done (5) . Management includes delivering the fetus and antibiotic therapy. Endometritis, or infection of the uterine lining occurs after up to 3% of vaginal deliveries and is even more common after cesarean deliveries (47) . As the infection is typically polymicrobial, treatment centers on broad-spectrum antibiotics. For those who fail medical management, surgical intervention up to and including hysterectomy may be required. Other conditions unique to pregnancy and associated with the development of ARDS include trophoblastic embolism, obstetric hemorrhage-related causes, placental abruption, septic abortion, and retained products of conception (5, 27) .
Initial Management and Conventional Mechanical Ventilation
During much of pregnancy and the initial stage of any maternal decompensation, the best support for the fetus is to maintain a nonhostile intrauterine environment by supporting the mother. Thus, the overall approach to the treatment of ARDS in pregnancy closely follows that for the general population and includes supportive care while identifying and treating the underlying cause (5, 30) . Due to the normal physiologic changes of pregnancy and the need in later-term pregnancies to assess fetal well-being and plan for possible delivery, the management of ARDS in pregnancy does have differences. A suggested algorithm for evaluating and managing suspected ARDS in pregnancy is depicted in Figure 2 .
Physiologic Changes Affecting Management. The normal physiologic changes of pregnancy are reviewed in detail in another area of this supplement.
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such as intubation. By late pregnancy, women also have a chronic compensated respiratory alkalosis resulting in a decreased buffering capacity for any additional metabolic acidosis, as might occur with sepsis, and a decreased capacity for respiratory compensation. Furthermore, as reviewed later in this supplement, airway management of the pregnant woman can be complicated by a variety of factors.
A variety of hemodynamic changes also occur during pregnancy, including an increase in red cell mass with a disproportionate increase in plasma volume. This results in a dilutional anemia and a decrease in plasma oncotic pressure, with subsequent soft-tissue edema and an increased risk for pulmonary edema at lower hydrostatic pressures. Cardiac output also increases, in part to meet the increased metabolic demands of both mother and fetus. After about 20 wks of gestation, the uterus is large enough to compress the inferior vena cava when the mother is in the supine position, which can cause hypotension and tachycardia due to decreased venous return to the heart, making the left lateral decubitus position favored.
Perhaps most important and unique to the management of ARDS in pregnancy are the goals of respiratory support, which may vary throughout pregnancy as the respiratory alkalosis of pregnancy develops. Although a PaO 2 of 55 mm Hg and an SaO 2 of 88% would be tolerated in the general population, adequate fetal oxygenation requires a PaO 2 of Ն70 mm Hg, which corresponds to a maternal SaO 2 of about 95% (5). The effect of maternal hypercapnia on the fetus is not well defined. Limited data from high-risk neonates suggest that PaCO 2 levels of 45-55 mm Hg are tolerated (48) . Furthermore, clearance of fetal PaCO 2 by the placenta requires a gradient of approximately 10 mm Hg (49) . A goal for maternal PaCO 2 of Ͻ45 mm Hg, which corresponds to a maternal pH of Ͼ7.30, thus seems reasonable late in pregnancy.
Noninvasive Positive-Pressure Ventilation. Noninvasive positive-pressure ventilation (NIPPV) is positive-pressure ventilatory support delivered through a tightly fitting nasal or facial mask rather than through an endotracheal tube (50) . Although the largest amount of experi- ence is with hypercapnic respiratory failure, NIPPV can improve oxygenation when supplemental oxygen has failed and thus eliminate the need for endotracheal intubation. A small study on hemodynamically stable patients with ARDS and a slightly larger study on hypoxemic respiratory failure in neutropenic patients both found benefit (51, 52) . Other studies have not upheld these findings (53, 54) . NIPPV has not been evaluated for the treatment of hypoxemic respiratory failure during pregnancy, but it does seem to be a safe and effective treatment for sleepdisordered breathing during pregnancy and has been found to minimize the hemodynamic changes that accompany preeclampsia (55) (56) (57) . Furthermore, the overall prevalence of complications from NIPPV is less than the rate of complications from endotracheal intubation (50) . NIPPV can only be used in patients with adequate respiratory drive who are able to control their own airway and who are able to tolerate positive pressure through a tightly fitting mask. It should not be used in patients who are hemodynamically unstable or who are at high risk of aspiration. For women meeting appropriate criteria, a trial of NIPPV may be appropriate but only in a closely monitored setting due to the increased risks of airway compromise and aspiration in the obstetric population. Lung-Protective Conventional Ventilation. The broad goals of ventilatory support in a pregnant woman with ARDS are no different from the general population, namely, to manage blood gas variables while not causing ventilator-associated lung injury that could worsen the clinical picture or prolong the course. The clinical criteria for intubating a pregnant patient are similar to those in nonpregnant patients and include increased work of breathing, mental status deterioration, hemodynamic instability, and inability to protect the airway or manage secretions (30) . Blood gas criteria for intubation may vary depending on the gestational age of the pregnancy, but later in pregnancy, which is when most cases of ARDS in pregnancy occur, a normal PaCO 2 should be interpreted as a sign of impending respiratory failure. Inability to maintain a PaO 2 of Ͼ70 mm Hg, or an SaO 2 of Ͼ95%, with conservative therapy should also be interpreted as a sign of respiratory compromise requiring intubation. As covered in this supplement, the obstetric airway should be managed expeditiously by a skilled clinician.
The current approach to mechanical ventilation of a patient with ARDS emphasizes the use of lower tidal volumes with lower pressures to avoid causing lung overdistension and ventilatorassociated lung injury (tidal volume of Յ6 mL/kg predicted body weight and targeted inspiratory plateau pressures of Յ30 cm H 2 O) (58) . The ARDS Network trial demonstrated a statistically significant absolute reduction in mortality of nearly 9% using this approach compared with a larger tidal volume approach. Unfortunately, pregnancy was an exclusion criterion for this study and other studies evaluating potential lung-protective ventilation strategies (59) . It intuitively might seem that pregnant women could safely tolerate a higher inspiratory plateau pressure due to the decrease in chest wall compliance as pregnancy progresses. In a pregnant patient with ARDS, however, the overwhelming contribution to decreased compliance of the respiratory system comes from the lung injury and not the chest wall (49) . Adoption of the ARDS Network lung-protective strategy for ARDS in pregnancy is recommended as an extrapolation from the general ARDS population, using the same protocol and the nonpregnant predicted body weight but gestational age-appropriate blood gas targets.
A potential sequela of using a low tidal volume approach is the development of hypercapnia. Due to issues already discussed, the same degree of respiratory acidosis permitted in the general population may not be optimal when treating ARDS in pregnancy. In keeping with the ARDS Network protocol, respiratory rate should be increased to maintain pH and PaCO 2 but in ranges appropriate to the gestational age of pregnancy. If needed, the tidal volume can be increased provided the inspiratory plateau pressure remains at Ͻ30 cm H 2 O (49). Respiratory alkalosis beyond what is normal for pregnancy should be avoided because it may diminish uterine blood flow and jeopardize the developing fetus (30) .
In addition to low tidal volumes and limited plateau pressures, the ARDS Network protocol prescribes allowable combinations of FIO 2 and positive endexpiratory pressure. This portion of the protocol should also be used unchanged in treating pregnant women with ARDS. Details regarding usage of the ARDS Network low-tidal volume mechanical ventilation strategy are available on-line at https:// www.ardsnet.org/studies.php.
Strategies for Patients Failing Conventional Mechanical Ventilation
Some patients with severe ARDS may develop oxygenation failure, despite the use of conventional ventilation with a higher FIO 2 (Ͼ60%) or a higher inspiratory plateau pressure (Ͼ30 cm H 2 O) than have been recommended as lung protective. For these severely ill patients, alternative approaches include the use of airway pressure-release ventilation (APRV), high-frequency oscillatory ventilation (HFOV), lung recruitment maneuvers (LRMs), prone positioning, and inhaled nitric oxide. Although none of these modalities has yet been demonstrated to reduce mortality in the general ARDS population (adequately designed and powered, randomized, controlled trials have not yet been performed), they have been associated with improved oxygenation in observational and small clinical trials and may be considered for patients who seem to be failing conventional lung-protective, volume-cycled ventilatory approaches.
Additional modalities that may be available at some centers include pumpless extracorporeal interventional lung assist devices (e.g., Biolung, Novalung, Hechingen, Germany) and conventional pump-driven extracorporeal oxygenation systems. The use of interventional lung assist devices and extracorporeal oxygenation is beyond the scope of this review and is not widely available in the United States for the management of adult ARDS. The use of these modalities in adult or obstetric ARDS should be within the context of controlled clinical trials.
LRMs. LRMs consist of brief (30 -60 secs) sustained inflations at relatively high airway pressures (40 -50 cm H 2 O) that may be employed during conventional ventilation, APRV, or HFOV with the aim of opening atelectatic alveoli and improving oxygenation. An LRM may be particularly important to consider if a patient has abrupt oxygen desaturation after a "de-recruiting" event (e.g., circuit disconnect, bronchoscopy, or suctioning) or has remained severely hypoxic despite optimized mechanical ventilation in any mode used (60, 61) . Although the concept of performing LRMs as an adjunct to achieving optimal lung recruitment and oxygenation is conceptually attractive, clinical trials demonstrating durable benefit or beneficial mortality outcomes remain few (62) (63) (64) (65) .
APRV. APRV was first described in 1987 as an alternative method of ventilatory support in the presence of acute lung injury and inadequate oxygenation (66) . It facilitates oxygenation by applying continuous positive airway pressure and ventilation, or CO 2 removal, by using programmable, intermittent releases in airway pressure. In addition, spontaneous breathing can occur throughout the respiratory cycle, which further promotes oxygenation and ventilation and which distinguishes this mode from inverseratio pressure-control ventilation. Spontaneous breathing during APRV has been associated with reduced vasopressor requirements, improved cardiac output and renal function, and may reduce requirements for sedatives and paralytics (67) (68) (69) . Spontaneous breathing during APRV can be facilitated by the adjunctive use of ventilator algorithms, such as automatic tube compensation, designed to compensate for the resistance of the endotracheal tube by transiently increasing delivered flow during inspiration and lowering airway pressure during exhalation (70) .
Theoretical aspects and practical clinical usage of APRV have been reviewed (66, 71) . The following is a brief summary of one method for initiating APRV in adults with ARDS who seem to be failing conventional ventilation. P high is initially set at 30 cm H 2 O or at either the inspiratory plateau pressure or 75% of P peak observed during conventional ventilation. P low is initially set at 0 cm H 2 O. T high is set at 4 secs and T low is set at 0.8 secs, yielding a respiratory cycle time of approximately 5 secs or 12 programmed exhalations per minute. The goal is for T low to be long enough to allow for ventilation to take place but to return to P high before exhalation is complete, thus producing a degree of auto-positive endexpiratory pressure. It is important to monitor minute ventilation, exhaled tidal volume, and auto-positive end-expiratory pressure to assess the trends anticipated in oxygenation or ventilation as changes in settings are made. As oxygenation improves, patients can either be returned to conventional ventilation or they can be weaned from APRV directly to continuous positive airway pressure by gradually lowering P high and increasing T high .
HFOV. HFOV is another mode of mechanical ventilation to consider for patients who remain hypoxemic despite optimized low tidal volume lung-protective conventional ventilation or APRV. In contrast to APRV, the patient must make a transition to a specialized ventilator (SensorMedics 3100B, ViaSys Healthcare, Yorba Linda, CA). HFOV utilizes low tidal volumes (approximate range, 50 -200 mL) at extremely high respiratory rates (range, 200 -900 breaths/min) superimposed on a relatively constant mean airway pressure to maintain an "open lung" (72) . Because the lung is maintained open with relatively small tidal oscillations around the set mean airway pressure, overdistention (volutrauma) and reopening lung injury (atelectrauma) are conceptually minimized. For these reasons, HFOV may represent an attractive ventilator modality less likely to perpetuate lung injury already present from ARDS.
Several observational and randomized trials have suggested improved oxygenation and safety with this mode of ventilation (73) (74) (75) . Details regarding the theoretical concepts and practical clinical usage of HFOV have recently been published (76) . Patients moved to HFOV generally require deeper sedation than patients receiving conventional ventilation and may require intermittent neuromuscular blockade. We are unaware of any reports on the use of HFOV in obstetric ARDS. Based on the experience with HFOV for severe ARDS in the general population, however, we believe HFOV may be considered for a trial of therapy in select pregnant patients failing conventional ventilation. Patients who improve with HFOV must eventually be switched back to APRV or conventional ventilation for weaning before extubation.
Prone Positioning. Prone positioning was known to improve oxygenation in patients with ARDS as early as 1976 (77) . Numerous reports have since demonstrated improved PaO 2 in ARDS patients who undergo prone positioning. With prone positioning, up to 70% of ARDS patients have a Ͼ20% improvement in PaO 2 , which may allow for decreases in FIO 2 and positive end-expiratory pressure. The mechanism of this effect is unclear but is believed to stem from a more uniform distribution of pleural pressure gradients, resulting in greater ventilation of dependent lung segments. Prone positioning is thus, in essence, a recruitment maneuver. Interestingly, during prone positioning, the effect of LRMs on oxygenation is both increased and prolonged (78, 79) . As with the performance of LRMs, an adequately designed and powered clinical trial has not yet been performed documenting mortality benefits with prone positioning (80, 81) . To our knowledge, the use of prone positioning in severe obstetric ARDS, particularly close to the estimated time of delivery when aortocaval compression by gravid uterus may occur, has not been reported. If a pregnant patient with severe ARDS is close to term, it may be better to maintain the left lateral decubitus position to optimize venous return and defer prone positioning until after delivery if severe oxygenation impairment persists. Following a careful algorithm for prone positioning is essential for patient safety (82) .
Inhaled Nitric Oxide. The use of inhaled nitric oxide (iNO) to improve oxygenation in patients with ARDS was first reported in 1993 (83) . Although therapeutic iNO has multiple potential mechanisms of action, its use in ARDS is primarily based on its known properties as a selective pulmonary vasodilator with resultant improvement in ventilationperfusion matching (84) . In addition, elevated pulmonary artery pressures and pulmonary vascular resistance may be improved with iNO. Unfortunately, clinical use of iNO in patients with adult ARDS has been disappointing, with only short-lived oxygenation improvement and no demonstrated improvement in mortality (85, 86) . If iNO is used (as a clinical trial) for severe hypoxemia, the dose requirement (parts per million) should be reassessed daily because it may actually decrease over time because patients may develop more sensitivity to the drug (87) . One method for using iNO is as follows (88) . When initiating iNO, begin at 2.5 ppm and assess PaO 2 10 mins afterward. Proceed stepwise through 5, 10, 20, 30 , and up to a maximum of 40 ppm until there is a Ͻ5% change in PaO 2 from the previous assessment. Each morning, the dose is decreased in the same stepwise fashion, with additional steps below 2.5 ppm of 1, 0.5, and 0, until there is a Ͼ5% decrease in PaO 2 between steps. The dose should then be returned to the last dose before the Ͼ5% decrease occurred. It there is not at least a 20% improvement in PaO 2 from baseline, iNO should be discontinued. To our knowledge, the use of iNO to improve oxygenation has not been evaluated in pregnant patients. However, select obstetric patients with severe pulmonary hypertension associated with ARDS may benefit from a trial of iNO. Monitoring exhaled gas for nitrogen dioxide and blood methemoglobin levels is essential during iNO therapy. Currently, adult ARDS is not a Food and Drug Administration-approved indication for iNO in the United States.
Fetal Monitoring and Decisions Related to Delivery
Shortly after beginning care for a pregnant woman with ARDS, fetal assessment should take place and plans for possible delivery should be made (89) . These plans are influenced by the gestational age of the fetus, fetal status, maternal status, and the gestational age at which the treating institution can support a preterm infant, which is often 24 -26 wks for larger centers. Before a viable gestational age is reached, delivery is not an option, other than for termination, and monitoring is limited to Doppler auscultation of fetal heart tones to determine whether the fetus is still viable. Recently published guidelines suggest twice-weekly antepartum testing starting at about 26 wks for high-risk conditions and for any significant deterioration in fetal status (90) . We further recommend testing for any change in maternal status or therapy that may adversely affect the fetus, such as hypotension or increased doses of inotropes, new or worsening maternal acidosis regardless of cause, hypoxemia, increased FIO 2 , or ventilator changes resulting in an increase in mean airway pressure.
Electronic Fetal Monitoring. Electronic fetal monitoring consists of assessing fetal heart rate and uterine activity over a period of time (89) . The fundamentals of interpretation have been reviewed elsewhere and consist of assessing the fetal heart rate variability, particularly in response to contractions (91) . Fetal heart rate variability does not occur until approximately 28 wks of gestation, and a variety of other maternal-fetal factors can result in a non-reassuring pattern without fetal compromise being present (89, 91) . Thus, although electronic fetal monitoring can play a major role in assessing the fetal response to maternal instability, it is not appropriate in all critically ill pregnant patients (91) . Furthermore, electronic fetal monitoring should be used only when a practitioner able to interpret and act on the information obtained is present.
Biophysical Profile Scoring. Fetal biophysical profile (BPP) scoring is based on the theory that fetal asphyxia will elicit consistent, protective fetal responses that can be monitored by ultrasound, including changes in breathing movements, tone, limb movements, and heart rate variability (89) . The amount of amniotic fluid, which includes fetal urine, is also assessed and provides a surrogate measure of fetal renal perfusion over time. BPP scoring thus provides an assessment of both the acute fetal state, with relatively precise correlation between the BPP score and fetal pH, and the chronic fetal condition (92) . Fetal growth, which gives additional information about the chronic fetal condition, can also be assessed during the BPP ultrasound (89) . Fetal biophysical behaviors do not fully mature until after 28 -32 wks of gestation, and thus, interpretation of a BPP obtained before that time can be limited (89, 93) . BPP scoring is the recommended approach to assessing fetal wellbeing (90) .
Decisions Related to Delivery. Up until 32-34 wks of gestational age, the premature fetus is generally better supported in utero than outside the womb. A small retrospective study conditionally suggested that delivery may improve maternal status in ventilated women, and some authors have suggested elective delivery for women in late pregnancy who have ARDS but are clinically stable (5, 94) . Other studies have not supported an improvement (10, 11) . Given the risks of inducing labor or performing a cesarean, the indications for delivery should remain the standard obstetric indications until more evidence is available.
Little literature exists to guide the de-cisions on the mode of delivery. Although vaginal delivery may not be tolerated in a woman with ARDS due to increased oxygen consumption, cesarean delivery results in fluid shifts and blood loss that are both larger and more rapid than occurs with vaginal delivery and may present a greater physiologic stress (89, 96) . Until further data are available, the decision for a mode of delivery should be based on standard obstetric indications for cesarean delivery, and attempts should be made to optimize maternal oxygenation and pain control during vaginal deliveries (89) . Perimortem Cesarean Delivery. In the event of maternal cardiopulmonary arrest, the American College of Obstetricians and Gynecologists recommends that cesarean delivery be initiated within 4 mins for the benefit of both the mother and the fetus (97) . Improved outcomes in case reports support these recommendations (98) . The presumed explanation is that evacuation of the gravid uterus relieves aortocaval compression and improves maternal cardiac output. Due to the pressing maternal indications for the procedure and the time that would be involved, documentation of fetal status before delivery is not indicated. However, the fetus must be of viable gestational age for the institution where the procedure is performed. Maternal resuscitation efforts must continue through delivery. If maternal resuscitation is successful, and the cesarean has not yet been started, delivery is not immediately indicated as in utero fetal resuscitation will likely be successful. In the absence of fetal distress, anticipated cardiac arrest in an unstable patient is not an indication for cesarean delivery.
Given the poor outcomes detailed earlier in this article and the complexity of the decisions related to delivery, early multidisciplinary consultation is essential to optimize maternal and fetal outcomes. Maternal-fetal medicine, neonatology, anesthesiology, and intensivist clinicians should all be involved in planning for the timing, location, and mode of delivery in various scenarios (89) . For pregnancies that have reached the institutional gestational age of viability, the necessary surgical supplies and neonatal resuscitation supplies should also be readily available with minimal delay, perhaps near the bedside, in case emergent delivery in the ICU is required.
CONCLUSIONS
ARDS occurs in the obstetric population and may have unique causes. The recommended mechanical ventilation strategies are based on the low tidal volume approach outlined by the ARDS Network, which has been demonstrated to reduce mortality in the general ARDS population. Patients with persistent severe oxygenation failure may be considered for alternative ventilation approaches such as APRV or HFOV. The risk-benefit ratio of adjunctive modalities such as iNO or prone positioning in the obstetric patient population remains uncertain. Early assessment of fetal wellbeing and multidisciplinary consultation to develop a delivery plan are unique to managing ARDS in pregnancy and are essential to optimizing both maternal and fetal outcomes.
